UTRECHT, The Netherlands and PHILADELPHIA, March 05, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (LVTX) (NASDAQ: LVTX, “LAVA”), a clinical-stage immuno-oncology company focused on developing its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results